TY - JOUR
T1 - Immunohistochemical analysis of cathepsind expression in primary breast carcinomas
AU - Naidu, R.
AU - Yadav, M.
AU - Nair, S.
AU - Kutty, M. K.
N1 - Copyright:
Copyright 2006 Elsevier B.V., All rights reserved.
PY - 1998
Y1 - 1998
N2 - Cathepsin-D is a lysosomal protease implicated in cancer métastases and its association in breast carcinomas appears to be of prognostic significance. In the present study expression of cathepsin-D was evaluated in 134 primary breast carcinomas fixed in formalin and paraffin embedded using immunohistochemical technique. Expression of cathepsin-D was analyzed in relation to clinico-pathologica! parameters and tumor markers such as epidermal growth factor receptor (EGFR), c-erbB2 and p53. Overexpression of cathepsin-D was detected in 54% of comedo ductal carcinoma in situ (DCIS), 65% of invasive ductal carcinomas, 71% of carcinomas containing both the in situ and invasive lesions and 20% of invasive lobular carcinomas. Significant association was observed between strong immunopositivity of cathepsin-D and lymph node status, high histological grade and EGFR but not with estrogen receptor, age of patient, c-erbB2 and p53. These observations suggest that overexpression of cathepsin-D in noninvasive, noninvasive and invasive in the same lesions and invasive carcinomas indicates that cathepsin-D may be involved in promoting tumor invasion. Its association with lymph node métastases, high tumor grade and EGFR shows that cathepsin-D may have potential to be an indicator for poor prognosis.
AB - Cathepsin-D is a lysosomal protease implicated in cancer métastases and its association in breast carcinomas appears to be of prognostic significance. In the present study expression of cathepsin-D was evaluated in 134 primary breast carcinomas fixed in formalin and paraffin embedded using immunohistochemical technique. Expression of cathepsin-D was analyzed in relation to clinico-pathologica! parameters and tumor markers such as epidermal growth factor receptor (EGFR), c-erbB2 and p53. Overexpression of cathepsin-D was detected in 54% of comedo ductal carcinoma in situ (DCIS), 65% of invasive ductal carcinomas, 71% of carcinomas containing both the in situ and invasive lesions and 20% of invasive lobular carcinomas. Significant association was observed between strong immunopositivity of cathepsin-D and lymph node status, high histological grade and EGFR but not with estrogen receptor, age of patient, c-erbB2 and p53. These observations suggest that overexpression of cathepsin-D in noninvasive, noninvasive and invasive in the same lesions and invasive carcinomas indicates that cathepsin-D may be involved in promoting tumor invasion. Its association with lymph node métastases, high tumor grade and EGFR shows that cathepsin-D may have potential to be an indicator for poor prognosis.
UR - http://www.scopus.com/inward/record.url?scp=33749860231&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:33749860231
SN - 0886-3849
VL - 13
SP - 37
EP - 47
JO - Journal of Tumor Marker Oncology
JF - Journal of Tumor Marker Oncology
IS - 4
ER -